31 results found.
    
ConforMIS, Orthofix and OrthoPediatrics Report Preliminary 4Q18 and FY 2018 Results
ConforMIS, Orthofix and OrthoPediatrics reported preliminary 4Q18 and FY 2018 results.
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
ConforMIS Reports 3Q18 Product Revenue of $18.3MM, +0.9% vs. 3Q17
ConforMIS posts 3Q18 product revenue of US $18.3MM, +0.9% vs 3Q17.
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
ConforMIS Posts 2Q18 Revenue
ConforMIS announced 2Q18 revenue of US $19.1MM, +3.3% vs. 2Q17, and 1H18 revenue of $38.8MM, -0.5% vs. 1H17.
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
ConforMIS Posts 1Q18 Revenue
ConforMIS announced 1Q18 revenue of US $19.7MM, -3.9% vs. 1Q17.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
ConforMIS Reports 4Q17, 2017 Revenue
ConforMIS posted 4Q17 revenue of US $20.8MM, -3.9% vs. 4Q16, and 2017 revenue of $78.1MM, -2.1% vs. 2016.
ConforMIS Reports Preliminary 4Q17, 2017 Revenue
ConforMIS announced preliminary 4Q17 revenue of US $20.8MM, -4.0% vs. 4Q16, and 2017 revenue of $78.1MM, ...
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
ConforMIS Reports 3Q17 Revenue
ConforMIS posted 3Q17 revenue of US $18.4MM, -1.2% vs. 3Q16, and YTD revenue of $57.4MM, -1.5% vs. the prior yea...
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
ConforMIS Posts 2Q17 Revenue
ConforMIS posted 2Q17 revenue of US $18.5MM, -4.4% vs. 2Q16, and 1H17 revenue of $38.9MM, -1.6% vs. 1H16.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
ConforMIS Posts 1Q17 Revenue
ConforMIS posted 1Q17 revenue of US $20.5MM, +1.0% vs. 1Q16.
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
ConforMIS Company Profile
We're redesigning Company Profiles. To get the most current news and articles about ConforMIS in the interim, plea...
ConforMIS Reports 4Q16 and 2016 Revenue
ConforMIS posted 2016 revenue of US $79.8MM, +19.3% vs. 2015, with 4Q16 revenue of $21.6MM, +13.3% vs. 4...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
ConforMIS Reports 3Q16 Revenue
ConforMIS posted 3Q16 revenue of US $18.6MM, +34.1% vs. 3Q15. (Product revenue: U.S. $14.9MM, +43%; ex-U.S. $3.4MM, +14...
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
ConforMIS Posts 2Q16 Revenue
ConforMIS posted 2Q16 revenue of US $19.3MM, +0.6% vs. 2Q15. (Product revenue: U.S. $15.0MM, +27%; ex-U.S. $4.1MM, +4%
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group